4 completed, 2 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Urticaria Chronic: new trials by email Literature Review of Urticaria Chronic trials Research Report on Urticaria Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mediterranean and Low-Histamine Diets for Pediatric Chronic Spontaneous Urticaria Low-Histamine Diet, Mediterranean Diet - Urticaria Chronic | Not applicable | Recruiting | Saglik Bilimleri Universitesi | 63 | 2025-11-23 | 2026-09-04 |
| An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria Placebo, 0.5 mg epinephrine, 1 mg epinephrine - Urticaria Chronic | Phase 2 | Recruiting | ARS Pharmaceuticals, Inc. | 42 | 2025-07-09 | 2026-09-16 |
| A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials Briquilimab - Urticaria Chronic | Phase 2 | Terminated | Jasper Therapeutics, Inc. | 67 | 2024-11-26 | 2026-08-06 |
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% Fexofenadine Hydrochloride Topical Lotion 1% (OP2101) - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Completed | OrchestratePharma GmbH | 12 | 2022-04-01 | 2023-03-29 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients UB-221 - Urticaria Chronic | Phase 1 | Completed | United BioPharma | 15 | 2019-04-09 | 2022-05-13 |
| Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU) Omalizumab - Urticaria Chronic | Phase 4 | Completed | Johns Hopkins University | 18 | 2017-10-06 | 2021-06-14 |
| Detection of Viral Particels in Urticaria Patients Urticaria Chronic | Completed | HaEmek Medical Center, Israel | 10 | 2017-07-02 | 2025-09-15 |
Chronic Urticaria (7) · Pruritus (2) · Dermatitis (1) · Dermatitis, Atopic (1) · Eczema (1) · Exanthema (1) · Psoriasis (1) · Urticaria (1)
Chronic Disease (7) · Disease Attributes (7) · Hypersensitivity (7) · Hypersensitivity, Immediate (7) · Immune System Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Skin Diseases (7) · Skin Diseases, Vascular (7) · Skin and Connective Tissue Diseases (7) · Urticaria (6) · Signs and Symptoms (2) · Skin Manifestations (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1)
Diet, Mediterranean (1) · Epinephrine (1) · Omalizumab (1)
ARS Pharmaceuticals, Inc. (1) · HaEmek Medical Center, Israel (1) · Jasper Therapeutics, Inc. (1) · Johns Hopkins University (1) · OrchestratePharma GmbH (1) · Saglik Bilimleri Universitesi (1) · United BioPharma (1)
United States (3) · Germany (2) · Bangladesh (1) · Israel (1) · Taiwan (1) · Turkey (Türkiye) (1)
Menachem Rottem (1) · Sarbjit Saini, MD (1)
R01AI116658 (1)